Market Research Logo

Blood Screening Market - Global Market Research 2015-2019

Blood Screening Market - Global Market Research 2015-2019

About blood screening

Blood screening is a medical process where blood is scanned for testing of particular condition or disease. This procedure is commonly performed for HIV, pregnancy, cancer, and other screening. It provides vital information to the physician regarding the functioning of organs such as kidney, liver, and thyroid. The major blood tests that are extensively used for diagnosing diseases include erythrocyte sedimentation rate (ESR), full blood count (FBC), electrolyte test, karyotyping, enzyme-linked immunosorbent assay (ELISA), C-reactive protein, liver function test, and blood cholesterol test. The market for blood screening has witnessed numerous technological advances such as shift toward the first-generation ELISA to highly advanced NAAT testing, since its inception.

Technavio's analysts forecast the global blood screening market to grow at a CAGR of 9.31% over the period 2014-2019.

Covered in this report

The report covers the current scenario and the growth prospects of the global blood screening market for the period of 2015-2019. To calculate the market size, the report considers revenue generated from the sales of instruments, assays/consumables, and services for the technologies such as NAAT and multiplexed real-time PCR

Technavio's report, Global Blood Screening Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, Europe, Latin America, MEA, and North America; it also covers the landscape of the global blood screening market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

  • APAC
  • Europe
  • Latin America
  • MEA
  • North America
Key vendors
  • Abbott Diagnostics
  • bioMérieux
  • Grifols
  • Roche Diagnostics
Other prominent vendors
  • Alere
  • BD
  • Beckman Coulter
  • Bio-Rad Laboratories
  • Cepheid
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Elitech
  • Enzo Biochem
  • Fujirebio/Innogenetics
  • Hologic
  • Immunetics
  • Lab21
  • Meridian Bioscience
  • OraSure
  • Ortho Clinical Diagnostics
  • Qiagen
  • SeraCare
  • Siemens Healthcare Diagnostics
  • Thermo Fisher Scientific
  • Trinity Biotech
Market driver
  • Increase in number of blood donations
  • For a full, detailed list, view our report
Market challenge
  • Limitation of closed system
  • For a full, detailed list, view our report
Market trend
  • Adoption of NAAT
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Blood Screening Market 2015-2019

Technavio recognizes the following companies as the key players in the Global Blood Screening Market: Abbott Diagnostics, bioMérieux, Grifols and Roche Diagnostics

Other Prominent Vendors in the market are: Alere, Bio-Rad Laboratories, BD, Beckman Coulter, Cepheid, Diamedix, DiaSorin, Elitech, Eiken Chemical, Enzo Biochem, Fujirebio/Innogenetics, Hologic, Immunetics, Meridian Bioscience, Lab21, OraSure, Ortho Clinical Diagnostics, Qiagen, SeraCare, Siemens Healthcare Diagnostics, Thermo Fisher Scientific, and Trinity Biotech.

Commenting on the report, an analyst from Technavio’s team said: “Researchers use advanced and sophisticated tools and software to manage huge volumes of blood samples and large megabytes of data for each sample. The electronic record systems help medical experts gain access to blood samples and study their genotypic and phenotypic information. For instance, Illumina and Affymetrix provide high-throughput single-nucleotide polymorphism genotyping systems for accessing and storing genotyped data. Similarly, the barcoding system and robust encryption algorithm help in the rapid identification and increase the safety of samples.”

According to the report, blood safety is an important parameter taken into consideration after blood donation and before transfusion. The spread of infectious diseases through contaminated blood transfusions has mandated many regulatory bodies worldwide to implement stringent measures for blood screening.

Further, the report states that the technical expertise of medical professionals using these devices is not up to par, which results in operational and technological issues. These factors, though, have increased the demand for skilled medical professionals, they impede the adoption of technologically advanced diagnostic devices.

Companies Mentioned

Abbott Diagnostics, bioMérieux, Grifols, Roche Diagnostics, Alere, Bio-Rad Laboratories, BD, Beckman Coulter, Cepheid, Diamedix, DiaSorin, Elitech, Eiken Chemical, Enzo Biochem, Fujirebio/Innogenetics, Hologic, Immunetics, Meridian Bioscience, Lab21, OraSure, Ortho Clinical Diagnostics, Qiagen, SeraCare, Siemens Healthcare Diagnostics, Thermo Fisher Scientific, Trinity Biotech.

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
  • Market landscape
    • Market overview
      • Table Global blood screening systems market segmentation
    • Market size and forecast
      • Table Global blood screening systems market 2014-2019 ($ billions)
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by technology
    • Table Global blood screening systems market segmentation by technology
    • NAAT
      • Table Global NAAT systems market segmentation by adoption 2014
      • Table Grifols: Global NAAT systems market share 2014
      • Table Grifols: NAAT systems market share in US 2014
      • Table Grifols: NAAT systems market share in APAC 2014
      • Table Roche Diagnostics and Grifols: Global NAAT systems market share 2014
      • Table Percentage share of products used for blood screening 2014
      • Table Comparison of NAAT systems for simultaneous detection of HIV, HCV (RNA), and HBV (DNA)
      • Table Global NAAT systems market 2014-2019 ($ billions)
    • Multiplexed real-time PCR
      • Table Global multiplexed real-time PCR systems market 2014-2019 ($ billions)
      • Table Global blood screening systems market segmentation by technology 2014
      • Table Global blood screening systems market segmentation by technology 2019
      • Table Global blood screening systems market segmentation by technology 2014-2019
  • Market segmentation by product
    • Table Global blood screening systems market segmentation by product
    • Assays and consumables
    • Instruments
    • Services
      • Table Global blood screening systems market segmentation by product 2014
  • Geographical segmentation
    • Table Global blood screening systems market segmentation by geography 2014
    • Table Global blood screening systems market segmentation by geography 2019
    • Table Global blood screening systems market segmentation by geography 2014-2019
    • Blood screening systems market in Americas
      • Table List of blood donation organizations in Americas
      • Table Blood screening systems market in Americas 2014-2019 ($ billions)
    • Blood screening systems market in EMEA
      • Table List of blood donation organizations in Europe
      • Table Number of healthcare facilities in Europe with NAAT systems
      • Table Application of NAAT systems in Europe
      • Table Blood screening systems market in EMEA 2014-2019 ($ billions)
    • Blood screening systems market in APAC
      • Table List of blood donation organizations in APAC
      • Table Blood screening systems market in APAC 2014-2019 ($ billions)
  • Market drivers
    • Increase in blood donations
    • Awareness of blood safety
    • Advances in personalized medicine
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • Limitation of closed systems
    • Regulatory issues
    • Lack of skilled technicians
    • Complexity and low detection capability
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Implementation of NAAT
      • Table NAATs for blood screening
      • Table Difference between NAAT and ELISA
    • Initiatives in rare disease research
    • Strategic alliances
    • Advances in IT
  • Vendor landscape
    • Competitive scenario
    • Market share analysis 2014
      • Table Global blood screening systems market: Ranking of companies 2014
      • Table Grifols: Key takeaways
      • Table Roche Diagnostics: Key takeaways
      • Table Abbott Diagnostics: Key takeaways
      • Table bioMérieux: Key takeaways
    • Other prominent vendors
  • Key vendor analysis
    • Abbott Diagnostics
      • Table Abbott Diagnostics: Key business offerings
    • bioMérieux
      • Table bioMérieux: Clinical applications
    • Grifols
      • Table Grifols: Business segmentation by revenue 2014
      • Table Grifols: Business segmentation by revenue 2013 and 2014 ($ millions)
      • Table Grifols: Geographical segmentation by revenue 2014
    • Roche Diagnostics
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report